Cellular and molecular aspects of drug transport in the kidney

Slides:



Advertisements
Similar presentations
Dr. imrana ehsan. What do the kidneys do? The glomeruli “non-discriminantly” filter the blood, and the tubules take back what the body needs leaving.
Advertisements

Ischemic heart disease after renal transplantation
Common tubular secretory mechanisms for organic cations and anions
Pharmacokinetics of Peptide and Protein Therapeutics
Rudolfs K. Zalups, Sarfaraz Ahmad  Kidney International 
Volume 82, Issue 1, Pages 7-8 (July 2012)
Tubulointerstitial Injury Associated With Chemotherapeutic Agents
Volume 60, Issue 3, Pages (September 2001)
Michael Fritzenwanger, Ines Heid, Adolf Dörge  Kidney International 
Andrew M. Hall, MD, PhD, Bruce M
Membranous nephropathy: When and how to treat
Toxic Nephropathies: Core Curriculum 2010
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition Zhou F, Zhub L, Wang K, Murray M Advanced Drug Delivery.
Making sense of the sensor: Mysteries of the macula densa
Burden of chronic kidney disease: North Africa
A trail of research on potassium
Renal and extrarenal regulation of potassium
Kidney specific factors that enhance nephrotoxic risk are noted.
Autosomal dominant distal renal tubular acidosis and the AE1 gene
Volume 71, Issue 5, Pages (March 2007)
Bioavailable vitamin D in chronic kidney disease
Manoocher Soleimani, M.D., Charles E. Burnham  Kidney International 
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
A ‘complexity’ of urate transporters
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Volume 71, Issue 11, Pages (June 2007)
Volume 86, Issue 2, Pages (August 2014)
Volume 86, Issue 2, Pages (August 2014)
Regulation of renal tubular secretion of organic compounds
Volume 74, Issue 5, Pages (September 2008)
Volume 83, Issue 4, Pages (April 2013)
Volume 71, Issue 6, Pages (March 2007)
Transcellular movement of organic cations (OCs) and organic anions (OAs) in kidney proximal tubule epithelial cells. Transcellular movement of organic.
Arterial function after successful renal transplantation
Volume 72, Issue 2, Pages (July 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Human organic anion transporter 1 mediates cellular uptake of cysteine-S conjugates of inorganic mercury  Rudolfs K. Zalups, Amy G. Aslamkhan, Sarfaraz.
Volume 84, Issue 2, Pages (August 2013)
Renal albumin absorption in physiology and pathology
Volume 80, Issue 4, Pages (August 2011)
Copyright © 2013 Elsevier Inc. All rights reserved.
S. Susan Hedayati, Essam F. Elsayed, Robert F. Reilly 
New drug toxicities in the onco-nephrology world
Volume 56, Pages S29-S31 (November 1999)
Volume 60, Issue 2, Pages (August 2001)
Renal potassium channels: Function, regulation, and structure
Volume 73, Issue 9, Pages (May 2008)
Proximal tubule NaCl reabsorption.
Volume 61, Issue 5, Pages (May 2002)
Aminoacidurias: Clinical and molecular aspects
Latest findings in phosphate homeostasis
Volume 83, Issue 4, Pages (April 2013)
A new regulator of the vacuolar H+-ATPase in the kidney
Volume 72, Issue 4, Pages (August 2007)
Model of proximal ammonia transport.
Volume 70, Issue 3, Pages (August 2006)
Pharmacology American Journal of Kidney Diseases
Ischemic heart disease after renal transplantation
T cells and T-cell receptors in acute renal failure
Coordinated control of renal Ca2+ handling
Volume 55, Issue 5, Pages (May 1999)
Basolateral transport of drugs.
Volume 60, Issue 3, Pages (September 2001)
The proximal kidney tubule is the target for tenofovir-associated nephrotoxicities. The proximal kidney tubule is the target for tenofovir-associated nephrotoxicities.
Kidney factors that enhance risk for drug-induced nephrotoxicity.
Cisplatin (Cis) nephrotoxicity is, in part, related to its uptake by proximal tubular cells. Cisplatin (Cis) nephrotoxicity is, in part, related to its.
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Cellular and molecular aspects of drug transport in the kidney Ken-Ichi Inui, Satohiro Masuda, Hideyuki Saito  Kidney International  Volume 58, Issue 3, Pages 944-958 (September 2000) DOI: 10.1046/j.1523-1755.2000.00251.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Mechanisms of organic anion transport in renal tubular cells. Cellular uptake of organic anions across basolateral membranes (BLM) is mediated by OAT1 (1), which is an organic anion/dicarboxylate exchanger, and by OAT2 (2) and OAT3 (3). Anionic drug conjugates with glutathione may be extruded from cells into blood by MRP1 (4). Exit of cellular organic anions across brush-border membranes (BBM) is mediated by unidentified transmembrane potential-dependent organic anion transporter (5) and organic anion/anion (X-) exchanger (6). Bidirectional transport of hydrophobic anions such as methotrexate and folic acid in the brush-border membranes is mediated by OAT-K1 (7). OAT-K2 (8) may also participate in tubular reabsorption and/or secretion of hydrophobic anions such as bile acids, methotrexate, and prostaglandin E2. MRP2/cMOAT (9) may contribute to tubular secretion of anionic conjugates of hydrophobic compounds. Kidney International 2000 58, 944-958DOI: (10.1046/j.1523-1755.2000.00251.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Mechanisms of organic cation transport in renal tubular cells. Cellular uptake of organic cations across the basolateral membranes (BLM) is mediated primarily by membrane potential-dependent organic cation transporters such as OCT1 (1) and OCT2 (2). OCT3 (3) may contribute in part to the cellular uptake of organic cations. Exit of cellular organic cations across brush-border membranes (BBM) is mediated principally by unidentified H+/organic cation antiporter (4). P-glycoprotein (5) is involved in tubular secretion of hydrophobic drugs such as digoxin, anticancer agents, and some immunosuppressants (cyclosporine and tacrolimus). Kidney International 2000 58, 944-958DOI: (10.1046/j.1523-1755.2000.00251.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Mechanisms of oligopeptide transport in renal tubular cells. Filtered oligopeptides and several β-lactam antibiotics are reabsorbed across brush-border membranes (BBM) by H+-coupled oligopeptide cotransporters, low-affinity type PEPT1 (1) and high-affinity type PEPT2 (2). Cellular oligopeptides, which escape hydrolytic degradation by enzymes, and β-lactam antibiotics are translocated across basolateral membranes (BLM) by an unidentified peptide transporter. Kidney International 2000 58, 944-958DOI: (10.1046/j.1523-1755.2000.00251.x) Copyright © 2000 International Society of Nephrology Terms and Conditions